ATE477331T1 - Verfahren zum nachweis einer hiv-infektion - Google Patents

Verfahren zum nachweis einer hiv-infektion

Info

Publication number
ATE477331T1
ATE477331T1 AT07756200T AT07756200T ATE477331T1 AT E477331 T1 ATE477331 T1 AT E477331T1 AT 07756200 T AT07756200 T AT 07756200T AT 07756200 T AT07756200 T AT 07756200T AT E477331 T1 ATE477331 T1 AT E477331T1
Authority
AT
Austria
Prior art keywords
hiv infection
detecting hiv
infection
hiv
afd
Prior art date
Application number
AT07756200T
Other languages
English (en)
Inventor
Yuntao Wu
Dongyang Yu
Jeremy Kelly
Rebecca Yoder
Original Assignee
George Mason Intellectual Prop
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by George Mason Intellectual Prop filed Critical George Mason Intellectual Prop
Application granted granted Critical
Publication of ATE477331T1 publication Critical patent/ATE477331T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/42—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16—HIV-1, HIV-2
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Food Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
AT07756200T 2006-05-05 2007-05-04 Verfahren zum nachweis einer hiv-infektion ATE477331T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US79774506P 2006-05-05 2006-05-05
US89415007P 2007-03-09 2007-03-09
PCT/US2007/010750 WO2007130523A2 (en) 2006-05-05 2007-05-04 Compositions and methods for detecting and treating hiv infection

Publications (1)

Publication Number Publication Date
ATE477331T1 true ATE477331T1 (de) 2010-08-15

Family

ID=38624429

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07756200T ATE477331T1 (de) 2006-05-05 2007-05-04 Verfahren zum nachweis einer hiv-infektion

Country Status (6)

Country Link
US (2) US7662547B2 (de)
EP (2) EP2236620A3 (de)
AT (1) ATE477331T1 (de)
CA (1) CA2651317A1 (de)
DE (1) DE602007008398D1 (de)
WO (1) WO2007130523A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2521676T3 (es) 2008-07-08 2014-11-13 Board Of Regents, The University Of Texas System Nuevos agentes inhibidores de la proliferación y de la activación de transductores de señales y activadores de la transcripción (STATS)
US8450337B2 (en) 2008-09-30 2013-05-28 Moleculin, Llc Methods of treating skin disorders with caffeic acid analogs
CN102264743B (zh) 2008-11-25 2015-02-11 罗彻斯特大学 Mlk抑制剂及其使用方法
US20130109687A1 (en) * 2010-04-30 2013-05-02 Gary J. Nabel Methods of treating hiv infection: inhibition of dna dependent protein kinase
WO2013025700A1 (en) * 2011-08-15 2013-02-21 Albert Einstein College Of Medicine Of Yeshiva University Phosphocofilin: cofilin co-localization intensity as a predictor of metastic recurrence
US10821111B2 (en) 2011-11-30 2020-11-03 Emory University Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections
US10485800B2 (en) 2012-11-30 2019-11-26 The University Of Rochester Mixed lineage kinase inhibitors for HIV/AIDS therapies
TWI629720B (zh) * 2015-09-30 2018-07-11 Tokyo Electron Limited 用於濕蝕刻製程之溫度的動態控制之方法及設備
CN106074567A (zh) * 2016-07-05 2016-11-09 湖北医药学院 葫芦素b在制备蛋白磷酸酶2a癌性抑制因子抑制剂中的应用
IL268129B2 (en) * 2017-01-17 2023-11-01 Univ Bar Ilan Preparations and methods for controlling the activation and function of natural killer cells (NK (NATURAL KILLER) cells)
US12259388B2 (en) * 2018-01-23 2025-03-25 Virongy L.L.C. Cofilin phosphorylation for quantifying CD4 T cell damage and predict CD4 T cell recovery from anti-retroviral therapy
CN110194793B (zh) * 2018-02-26 2020-12-01 中国科学院武汉病毒研究所 一种抑制肌动蛋白重组的多肽及应用
CN118389605A (zh) * 2023-11-13 2024-07-26 艾斯克纳公司 利用多肽增强脂质纳米粒子细胞转染的化合物和方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5932221A (en) * 1997-10-30 1999-08-03 Day; Charles E. Genistin-enriched fraction from soy meal
US7052676B2 (en) * 2000-09-26 2006-05-30 The Regents Of The University Of Michigan Methods for inhibition of HIV replication using a small molecule inhibitor
CN1100564C (zh) * 2001-08-29 2003-02-05 周根发 用于治疗hiv感染的药物、其组合物及其用途
CN103211806B (zh) * 2003-05-27 2015-09-09 帝斯曼知识产权资产管理有限公司 新颖的营养药物性组合物及其用途
EP1542016A1 (de) 2003-12-11 2005-06-15 Institut Gustave Roussy PUMA, phosphoryliertes p53 und p38 MAPK als Marker für HIV-induzierte Apoptose in zirkulierenden T-Zellen eines infizierten Patienten
WO2005103654A2 (fr) * 2004-04-09 2005-11-03 Bioalliance Pharma Methode d’identification de composes actifs sur la replication du virus hiv.

Also Published As

Publication number Publication date
US20080064026A1 (en) 2008-03-13
EP2021496A2 (de) 2009-02-11
WO2007130523A2 (en) 2007-11-15
EP2236620A2 (de) 2010-10-06
CA2651317A1 (en) 2007-11-15
US7662547B2 (en) 2010-02-16
US20100292181A1 (en) 2010-11-18
EP2236620A3 (de) 2011-05-25
DE602007008398D1 (de) 2010-09-23
EP2021496B1 (de) 2010-08-11
WO2007130523A3 (en) 2008-06-19

Similar Documents

Publication Publication Date Title
DE602007008398D1 (de) Verfahren zum nachweis einer hiv-infektion
EP4419159A4 (de) Vorrichtung zur gerinnselauffindung
EP4171423C0 (de) System zur erkennung von fehlstellungen
ATE531820T1 (de) Gesundheitszustandstest
EP3796297A4 (de) Anzeigetafel und risserkennungsverfahren dafür sowie anzeigevorrichtung
ATE499602T1 (de) Signalprozessierungsschaltkreis mit ionensensitivem feldeffekttransistor sowie verfahren zur überwachung einer eigenschaft einer flüssigkeit
BRPI0923772A2 (pt) artigos absorventes com indicadores visuais de saturação e áreas de marcação primárias e secundárias.
EP4091585C0 (de) Vorrichtung zur behandlung von refluxösophagitis
ATE537098T1 (de) System und verfahren zur erfassung der position einer aufzugskabine
ATE498134T1 (de) Nachweis von staphylococcus
DK2310043T3 (da) Von Willebrand faktor eller faktor VII samt von Willebrand faktor til behandling af koagulationsdefekt induceret af trombocythæmmere
EP3823217A4 (de) Verfahren zur messung von netzströmen, vorrichtung zur messung von netzströmen und vorrichtung auf steuerebene
FR2998580B1 (fr) Marqueurs moleculaires et methodes pour l'identification des genotypes de palmier dattier
EP4129753C0 (de) Vorrichtung zur erkennung einer gleitkontaktlinie und system zur erkennung einer gleitkontaktlinie
MX2019011702A (es) Ensayos de inmunogenicidad mejorados.
EP3847459C0 (de) Systeme, sensoren und verfahren zur bestimmung einer konzentration eines analyten
EA201201363A1 (ru) Датчик ионов для текучей среды и способ его изготовления
DE602005021866D1 (de) Vorrichtung zur verhinderung einer lateralen verschiebung für stabilisatoren
ATE486878T1 (de) Benzothienopyridine zur verwendung als inhibitoren von eg5-kinesin
ATE446572T1 (de) Verfahren und system zur bereitstellung eines tonsignals mit erweiterter bandbreite
DK2064548T3 (da) Fremgangsmåde til bestemmelse af transportaktivitet af et transportprotein
EP3940081C0 (de) Verfahren zur detektion von periodontopathischen bakterien
DE50108910D1 (de) Vorrichtung zur erfassung der pmd von optoelektronischen übertragungsstrecken
EP4323939C0 (de) System zur erkennung von fälschungen
EP4246456C0 (de) Vorrichtung zur detektion einer anschlaglinie

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties